Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Victoria Jeyarani"'
Autor:
Antony Justin, Premkumar Ashwini, Jincy A. Jose, Victoria Jeyarani, S. P. Dhanabal, Chennu Manisha, Subhankar P. Mandal, Guru Bhavimani, P. Prabitha, S. Yuvaraj, B. R. Prashantha Kumar
Publikováno v:
Frontiers in Neuroscience, Vol 14 (2020)
The present study has planned to evaluate the neuroprotective activity of two novel glitazones in a neuroinflammatory rat model. Two novel glitazones were selected from an in-house virtual library of glitazones based on their docking scores against p
Externí odkaz:
https://doaj.org/article/cc3b8fe2fcde4d8188a33fe9020b504b
Autor:
P. Prabitha, B. R. Prashantha Kumar, Victoria Jeyarani, Ashwini Prem Kumar, S P Dhanabal, Antony Justin
Publikováno v:
Mini-Reviews in Medicinal Chemistry. 21
The transcriptional factor PPAR-γ belongs to the nuclear receptor family, which has become a potential therapeutic target for several neurodegenerative diseases and metabolic disorders. Interestingly, PPAR-γ has been reported to have beneficial eff
Autor:
Chennu Manisha, Jeyaram Bharathi Jeyabalan, Jincy A. Jose, Victoria Jeyarani, B. R. Prashantha Kumar, Sayani Banerjee, P. Prabitha, Antony Justin, Sandhya Chipurupalli, S P Dhanabal, Suresh Kumar Mohankumar, Ashwini Prem Kumar, S. Yuvaraj
Peroxisome proliferator-activated receptor gamma (PPAR-γ) is one of the ligand-activated transcription factors which regulates a number of central events and considered as a promising target for various neurodegenerative disease conditions. Numerous
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2768b188ac4dc7cd6ab6df95ec412b07
https://cronfa.swan.ac.uk/Record/cronfa57371
https://cronfa.swan.ac.uk/Record/cronfa57371
Autor:
Peet Thomas, Victoria Jeyarani, Tenzin Choephel, Justin Antony, Satadal Debroy, Chennu Manisha
Publikováno v:
Research Journal of Pharmacy and Technology. 12:2200
Cases of Diabetes mellitus around the world are increasing day by day. It has been predicted that India, China and United States will be having the largest number of diabetic patients by 2030. Therefore, the anti-diabetic study is attracted a huge nu
Publikováno v:
Research Journal of Pharmacy and Technology. 12:3951
Neurological disorders such as Alzheimer’s Disease (AD), Parkinsons’s Disease (PD) and Cerebral Ischemic Stroke (CIS) are responsible for morbidities in almost a billion people and it is rising with increase in older population. AD is responsible